Published Mar 22, 2024

Sam Ifergan from iGan Partners

Sam Ifergan of iGan Partners delves into de-risking early medtech investments, the transformative impact of AI on healthcare, and overcoming commercialization challenges within the Canadian healthcare system, offering strategic insights for fostering innovation and ensuring successful exits.

Episode Highlights

Topics covered

Investing Strategies
01
Canadian Healthcare Innovation
02
Commercialization Challenges
03

Questions from this episode

How does AI change venture capital?
Asked by 81 people
How can the venture ecosystem change?
Asked by 62 people
How do big acquisitions happen, and what role does venture capital play in that process?
Asked by 57 people

Sam Ifergan from iGan Partners

Topics covered

Popular Clips

AI Transformation Insights

Tech Exits and Investment Cycles

Startup Funding Challenges

Innovation Ecosystems

Funding Challenges

Strategic Business Exits

Medtech Funding Insights

Navigating Tough Times

MedTech Insights

Fundraising Insights

Value Adds & Commercialization

Investing Strategy Evolution

Canadian Healthcare Challenges

Breakthroughs in Imaging

Questions from this episode

How does AI change venture capital?

How can the venture ecosystem change?

How do big acquisitions happen, and what role does venture capital play in that process?

Episode Highlights

Investing Strategies

Canadian Healthcare Innovation

Commercialization Challenges

Sam Ifergan from iGan Partners

Topics covered

Popular Clips

Questions from this episode

Episode Highlights

Investing Strategies

Canadian Healthcare Innovation

Commercialization ChallengesThe medtech industry faces distinct challenges in sales and exit strategies, requiring companies to navigate complex sales cycles and strategic partnerships. Sam Ifergan shares insights on overcoming these hurdles and the importance of planning for viable exits.

Commercialization Challenges